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To try epidermis as a target for somatic gene therapy 
we studied transfected primary human keratinocytes 
grovvn in culture and grafted onto athymic mice. We 
have developed a novel technique for grafting cultured 
epidermal sheets onto mice. First, the graft is placed on 
the dorsal muscle fascia underneath the mouse skin 
using the latter as a bandage. Secondly, the mouse skin 
above the graft is removed, which exposes the grafted 
skin to open air and thus stimulates terminal difFeren-
tiation. A novel method for the discrimination be-
tween murine and human epidermal cells is also 
presented, employing in situ hybridization with 
hUJDan Alu repeated DNA sequences. 
During monolayer culture the keratinocytes were 
lipof"ected with the gene for human growth hormone 
in an Epstein-Barr virus-based expression vector. The 
cells were allowed to develop a multilayered tissue for 
T he transplantation of cultured keratinocytes onto ath-ymic animals has numerous applications. It may be used to optimize the grafting techniques of severe burns [1], or to study events occurring during the ter-minal differentiation of normal or pathologic epider-
mis [2,3]. It may also be used in the context of gene therapy either to 
produce an organoid deliveri~g or :emoving specific products sys-
temically [4-7] or as a genetically Improved graft that locally can 
deliver products like growth factors that could stimulate wound 
healing and the formation of a more developed dermis. Fenjves et at 
[4] showed that human apolipoprotein E (Apo E) was secreted into 
the blood of nude mice after the transplantation of cultured human 
primary keratinocytes. Using a carcinoma cell line transfected with 
the gene encoding human growth hormone (hGH), Teumer et at [5] 
showed it possible to detect this exogenous protein after the trans-
plantation of the c~rcinoma cell sheet upside down. under the mou~e 
skin . The coagulation factor IX has also been translently detected m 
the blood of nude mice after the grafting of retrovirally transduced 
human primary keratinocytes [6] . 
In the present study, we have transfected primary keratinocytes 
Manuscript received December 16, 1993; accepted for publication April 
29, 1994. 
Reprint requests to: Vffe BirkJensen, Institute of Human Genetics, The 
Bartholin Building, Aarhus University, DK-BOOO Aarhus, Denmark. 
Abbreviations: ApoE, apolipoprotein E; hGH, human growth hormone; 
K-SFM, keratinocyte serum free medium. 
5 d, secreting human growth hormone into the me-
dium at a daily rate of at least 50 ng/ cm2 of tissue. 
The transfected tissues were then grafted onto mice. 
We detected human growth hormone at levels of up to 
2.6 ng/ml in mouse serum for 4 d, but later no human 
growth hormone could be found, although the trans-
plants survived for months. To investigate the fate of 
the transfected cells in the transplanted tissue, we la-
beled them with the p-galactosidase reporter gene. The 
cells staining positive for X-gal were found exclusively 
in the most superficial differentiated layers at 7 dafter 
transplantation. This may be the main reason why no 
human growth hormone is found in the mouse circu-
lation at this time. Key words: grafting/nude mice/ 
transfection/skin/culture. ] Invest Dermatol 103:391-
394,1994 
grown in monolayer. When the culture had been allowed to differ-
entiate and stratify for 5 d, the resulting tissue was transplanted onto 
nude mice. The grafting technique described in this work was de-
veloped wi~~ the final goal to establish a permanent transplant in a 
normal positIOn. The technique is simple and avoids the everted flap 
technique described by Barrandon et at [8] because this is difficult to 
perform in mice. 
MATERIALS AND METHODS 
Chemicals And Media PBS: Dulbecco's phosphate buffered saline with-
out calcium and magnesium. PBS-ethylenediamine tetraacetic acid (EDT A): 
PBS,0.3 mM EDTA. Dispase II (Neutral protease, Boehringer): 12.5 U /mi 
or 1.25 V /ml in Hanks' balanced salt solution (JRH, Seralab) . Trypsmstock, 
2.5% (JRH, Seralab). K-SFM: keratinocyte-serum-free medium including 
additives (Gibco, Life Technology). FBS: fetal bovine serum (Biocrom). Ep 
medium: Dulbecco's modified Eagle's medium (MEM) (Gibco, Life Tech-
nology), 15% FBS, EGF (epidermal growth factor, Collaborative Research 
Inc., Lexington, MA) 10 ng/ml, penicillin 250 units/mI, streptomycin 25 
Jlg/ml, L-glutamin 580 mg/l, and hydrocortisone 0.4 Jlg/mi . 
Cell Culture Human primary keratinocytes were isolated from speci-
mens obtained from reconstructive surgery as follows. Dermal side was 
cleaned from fat. The epidermal side was superficially cut every 5 mm to 
ensure access of the dispase. The specimen was then washed in PBS and 
incubated in 12.5 V/ml dispase II overnight at 4°C. The epidermis was 
peeled from the dermis with a pincer and transferred to PBS-EDTA for 10 
min at room temperature. Trypsin was added to a final concentration of 
0.025% w/v and the tissue was incubated for a maximum of20 min at 37 °C. 
Cells were dissociated by shaking the tube. Trypsin action was stopped by 
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adding t vol FBS and the cells were collected at 270 X g, 5 -10 min. Cells 
were counted and resuspended in complete K-SFM and plated at a density of 
2 X 105 cells/ cm2 in tissue-culture flasks. 
Transfection When the cu1tures were about ·85% confluent the cells 
were transfected by lipofection (DOTMA, Boeh_ringer) according to the 
manufacturer. The hGH expression vector was constructed as described by 
Jensen et al [9J except that a 2.15-kb genomic fragment (BamHI/EcoRI) 
encoding the hGH was inserted in the site controllc;d by the SV 40 promoter. 
The expression vector carrying the Lac Z gene was described by Jensen et al 
[10] . Epstein-Barr virus (EBV)-based expression. vectors were chosen be-
cause of their potential ability to become established as replicating episomes 
in human Iymphoblastoid cells and epithelial cell lines [11 J and because they 
display pronounced stability in human keratinocytes, giving high expression 
for months post-transfection. DNA-DOTMA complexes were added for a 
maximum of 16 h. The cells were washed once .in Ep medium, and then 
cultured in Ep medium to induce differentiation. The medium was changed 
every other day. 
After 5 d the transfected tissue was incubated in ··dispase II 1.25 U /ml 
made up in Hanks' balanced salt solution. When the central part of the 
epidermal sheet was still loosely attached to the f1.ask, the reaction was 
stopped by removing the dispase solution and adding pp medium. The flask 
was placed On ice and the top cut away with a h~t knife. Medium was 
removed and a piece of viscose rayon mesh (Melolite contact, Smith and 
N ephew Scandinavia A/S) 2 X 1.5 cm was placed onthe epidermal sheet to 
support the transplant. The transplant was loosened from the substrate and 
transferred to a petri dish, placed tissue side down, and covered with a sterile 
cover slip. Drops of Hanks' balanced salt solution wi~h 10 mM glucose were 
added to the edges of the cover slip in order to keep" the transplant moist. 
Transplantation Technique Step 1: female athy~c mice NMRI-nu/nu 
were anesthesized with avertin by intraperitoneal injection. Skin was 
cleaned in 5% potassium iodide in 50% ethano\. A 4 - 5-cm fissure was cut 
laterally on the dorsal side of the mouse. Loose connective tissue between the 
skin and the fascia of the dorsal muscles was removed by blunt dissection. 
The transplant was placed directly on the fascia of the dorsal muscles, tissue 
side down. The fissure in the mouse skin was then closed with Histoacryl 
Blue (B.Braun Melsungen AG, Germany), and covered with Tegaderm (3M 
Company, USA). This allows the transplant to be established without any 
mechanical disturbance from bandages. 
Step 2: on day 5, the mice were anesthesized with Hypnorm (Janssen 
Pharmaceutica N .V., Belgium) and Diazepam, Stesolid (OUMEX, A.L. 
Laboratory, NJ, USA) by intraperitoneal injection (because of induction of 
the cytochrome P-450 enzyme by avertin and related drugs it is recom-
mended to use anesthesia based on morphine during step 2) . The skin above 
the transplant was cleaned as described. The mouse skin was surgically 
removed to create a window exposing the entire transplant and a second 
piece of Melolite contact was placed over the wound area and kept in place 
with Tegaderm. The animals were kept at 26-28·C. 
In situ Hybridization After sacrificing the animal, the grafted area was 
removed and fixed overnight in 4% paraformaldehyde-PBS. Standard tech-
niques for paraffin sections were used. Five-micrometer sections were col-
lected onto slides coated with 3-amino-propyl-trietoxy-silane (Sigma, 
A-3648). Sections were deparaffinized in xylene, and dried from methanol. 
The tissue was treated with 100 )1g/ml proteinase K (Merck, 24 568) at 
37'C for 10 - 60 min in buffer composed of 100 mM Tris-HCI, pH 7.5, 
50 mM EDT A. Postfixation was performed in 1 % paraformaldehyde-PBS 
for 5 min, and the slides were then dried from methanol. Hybridization 
mixture was added and the sections were heated to 95 ' C for 7 min in a moist 
chamber. Sections were transferred to 42'C overnight. Hybridization mix-
ture: 50% form amide, 5 X SSC, 0.1% sodium dodecylsulfate (SOS), 2 X 
Denhards solution, 10% dextran sulphate, 25 )1g/ml salmon sperm DNA 
and 0.2 ng/)11 probe, Blur 8 alu repeat (12) inserred into a PUC vector. The 
entire plasmid was used after nick translation with digoxigenin-Iabeled 
dUTP. 
After incubation at 42 ' C, the sections were washed in 2 X SSC, 0.1% 
SOS,2 X 5 min at room temperature, then 0.1 X SSC, 10 min at 42· C. The 
final wash was in 2 X SSC, 0.1 % SDS for 5 min at room temperature. 
Immunostaining was performed with an alkaline phosphatase -
conjugated anti-digoxygenin Fab fragment, according to the manufacturer 
{Boehringer}. 
The histochemical visualization was achieved with 5-bromo-4-chloro-3-
indolyl phosphate (BClP) and nitro blue tetraiolium (NBT) [13). 
ft-Gal Staining of Grafts Tissue was prepared as described by Lemar-
chand et al [14]. The tissue was placed in fixative (2% formaldehyde, 0.2% 
glutaraldehyde in PBS) for 2 hand transfered into X-gal staining buffer 
[5 mM K4Fe(CN)6' 5 mM K3Fe(CN)6' 2 mM MgCI2 with 200 )1g/ml X-
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Figure 1. HGH secretion from tissue-cultured epidermal celis- Pri-
mary keratinocytes were transfected with vector without the hGH gene (e), 
or with the hGH gene inserted (11). Twenty percent of the medium was 
removed and replaced with new medium at each sample point. HGH was 
measured by enzyme-linked immunosorbent assay. 
gal] at 37'C for 6 h . Tissue was then postfixed in fixative for 2 h and 
embedded in paraffin. Paraffin sections, prepared as described above, were 
counterstained in hematoxylin and eosin. About 600 sections were analyzed. 
Enzyme-Linked lmmunosorbent Assay Human growth hormone was 
determined directly in the growth medium or mouse serum in a dilution 
1: 10 or undiluted, respectively. An immunofluorometric assay was used 
(OELFIA, Wallac, Turku, Finland) employing two monoclonal antibodies 
directed at different sites. The mouse serum was obtained from tail blood. It 
should be noted that the mice are very small (about 20 g), and that thisl imirs 
the amount of blood that can be harvested. We found that it was feasible to 
withdraw three portions of 120 III whole blood during 10 d and that this was 
of no harm to the animals. 
hGH Receptor Binding Assay A competition assay with IM-9 cells was 
performed according to de Meyts [15] and Lesniak et al [16J. IM-9 cells were 
washed and resuspended in assay buffer (100 mM Hepes, 120 mM NaCI, 
1.2 mM MgSO., 2.5 mM KCl, 15 mM Na acetate, 10 mM Glucose, 1 mM 
EDTA, and 1 % BSA, pH 7.4). The cells were incubated in 5 ml polypropyl-
ene tubes with 25)11 125I_hGH (22 kO/4.5 X 10-11 M) with or withom 
unlabeled hGH (22 kO, 3 X 10- 7 M), or with 25 )11 dilutions of sample in a 
total volume of 250)11 and a cell density of 1.5 X 107 cells/m\. The tubes 
were incubated at 30'C for 90 min. Thereafter 200)11 of the cell mixture 
was layered 011 top of 50 III di-N-butyl phthalate and the cells were centri-
fuged for 1 min in a microfuge at 9000 rpm to separate bound t25I-hGH from 
unbound. The tip of the tube containing the cells was cut off and the 
radioactivity bound to the cells was measured in a gamma-counter. Specific 
binding is causing a drop in radioactivity with rising concentrations ofhGH 
in the sample. 
RESULTS 
Primary cultures of adult human keratinocytes are readily trans-
fected at high frequency using standard transfection methods. W e 
have lipofected basal cell monolayers with an EBV -based expression 
vector [9) that carries a genomic insert of the gene encoding human 
growth hormone. By this protocol 5 - 10% transfected cells are 
achieved. The hGH gene is driven by an SV40 promoter and the 
daily secretion is at least 1250 ng of hGH from a 25 cm2 culture 
flask with 5 ml medium (Fig 1) . The binding affinity of the se-
creted hGH was shown in the IM-9 receptor assays to be similar to 
standard hGH (see Materials and Methods). The high expression and 
secretion from the keratinocytes gave us the hope that these primary 
cells could be used as an organoid to deliver non-epidermal protein 
products into the blood stream. To test this possibility the trans-
planted cultures were allowed to differentiate and stratify. The epi-
dermal sheets were then grafted onto nude mice. First the graft i 
placed on the dorsal faSCIa underneath the mouse skin and after 5 d, 
when the graft has taken, the overlying mouse skin is removed, 
allowing the graft to develop as an integument. 
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Figure 2. Human origin of transplanted keratinocytes. Tissue cul-
tured transfected human primary keratinocytes at day 20 after transplanta-
tion onto nude mice. The murine/humane junction is shown. aJ Hematox-
ylin/eosin staining. b) After itl situ hybridization with a digoxigeni11 l a~eled 
robe against human Alu DNA sequences, the nuclei of the human eplder-~a1 cells are positive (some are marked with arrows) when immunostained 
with an alkaline phosphatase conjugated anti-digoxygenin Fab fragment. 
Scale bars, 50/1.m. 
The transplantation technique presented here has a take fre-
quency close to 100% after the grafting step 1. After the second step, 
when the transplanted tissue is exposed to open air, the rate of 
success is dependent on the animal behavior and the efficiency of 
graft protection. About 50% ~f the grafts develop~d successfully as 
an integument that could survIve for months. Dunng closure of the 
wound after step 2, the graft area undergoes contraction to about 
50% of its original size . At this point (about 2 weeks after step 2) the 
graft is no lon~er fixed to the muscle fascia, ~ut c~n be moved quite 
easily, suggest1l1g that the sheet of connective tissue that was re-
moved during step 1 is reconstituted. This rapid formation of a 
murine "neo-dermis" is in good correlation with findings in burn 
patients after the graft~n.g.of autolog~us epidermis onto the muscle 
fascia [17]. After the 111ltlal contraCtion the graft seems stable for 
months. However, about a year after the transplantation the graft 
area becomes less conspicuous and eventually no human cells can be 
detected with certainty. Figure 2 shows the graft site and the verifi-
cation of the human origin by ill sitJl hybridization* at day 20 after 
transplanting the transfected keratinocytes. Using this approach it is 
possible to detect any type of human tissue on the mouse, without 
the need for species-specific antibodies for the relevant tissue. Upon 
grafting of human full skin it is possible to show the human origin 
of cells in vascular endothelium, fibroblasts, hair follicles, glands, 
and epidermis several months post grafting (data not shown). 
:j: Jensen UB, Jensen TG, Jensen PKA, Bolund L: Human keratinocytes 
transfected with growth factor genes in vitro form a multilayered tissue that 
can be transplanted onto nude mice: an approach to somatic gene therapy of 
skin ulcers (abstr). ] Itlvest Dermato! 98:827, 1992. 
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Figure 3. Human growth hormone in serum from nude mice trans-
planted with human primary keratinocytes after transfection with 
the hGH gene. Tail blood was placed on ice for 30 min and centrifuged for 
10 min to obtain serum. HGH was measured by enzyme-linked irnmunosor-
bent assay. The columns represent the mean of five nllce. Error bars, SD. 
Figure 3 shows the amounts of hGH in serum from five mice. 
The variation among the mice was large. However in all mice hGH 
was detected after 2 d. In three mice the concentration of hGH was 
rising from day 2 to day 4. The highest amount detected in the 
serum was 2.6 ngjml. At day 10 the levels were undetectable in all 
five mice. It should be noted that on day 5 the transplantation step 2 
is perfonned, which removes the mouse tissue above the graft. 
Thus, it is possible that hGH was only secreted upwards to be 
absorbed by the mouse tissue above the graft. Another possibility 
might be that secretion through the basement membrane is abol-
ished when the transfected cells are leaving the basement membrane 
to form differentiated cell layers as the tissue is maturing. To clarify 
the situation we used the Escherichia coli gene Lac Z to follow the 
transfected cells in a grafting experiment. Several cells staining pos-
itive for p-galactosidase were found at day 7, but exclusively in the 
stratum corneum (Fig 4), indicating that the transfected cells are 
rapidly lost from the basal cell layer. 
DISCUSSION 
Gene transfer to epidermal keratinocytes is of interest for many 
reasons. The cells are easily transfected to a high frequency [10]' and 
the expression of the genes introduced is remarkably high. Epider-
mis is easily accessible and the fact that 30 kd molecules like Apo E 
are secreted through the basement membrane to the systemic circu-
lation [4], and even larger molecules like albumin are transported 
into the epidermis [18], makes it a very tempting experimental 
system for somatic gene therapy. . 
In the present study we have used human primary keratinocytes 
to gain further insight into the possible application of somatic gene 
therapy on epidermal tissue. As shown in Fig 3 we find elevated 
amounts of hGH in the mouse serum on day 4 compared to day two. 
On day five, step 2 of the grafting technique is performed, which 
leaves the graft in its normal position as an integument. Five days 
later the amount ofhGH is undetectable. Several explanations could 
account for these results. One possibility is that the expressed gene is 
rapidly shut down as has been the suggested explanation for the 
decreasing amount of factor IX observed by Gerrard et al [6] . Alter-
natively, it might be a reflection of the keratinocytes secreting hGH 
primarily upwards to be absorbed by the mouse tissue above the 
graft or it may be due to transfer of the transfected cells into the 
suprabasal layers, where the hGH is excluded from reaching and 
penetrating the basement membrane. To elucidate the problem we 
transplanted keratinocytes transfected with the Lac Z gene onto 
nude mice. Several blue cells were found after 7 d, but all were ill the 
stratum corneum. None was found in the basal layer or the interme-
diate layers, supporting the idea that the transfected cells are rapidly 
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Figure 4. X-gal staining of human primary keratinocytes trans-
fected with the Lac Z gene at day 7 post grafting (2 d after grafting 
step 2). a) Hematoxylin/eosin staining. b) Eosin staining. Two positive ce\1s 
(arrows) are seen in the stratum corneum (SC) . Vaseline and debris from 
bandage (D) . Mouse "nco-dermis" (MD). Scale bar, 100 !lm. 
lost .from the basement membrane. The selective export of the 
transfected cells could be due to the very high expression of a for-
eign gene product, which might interfere with the programmed 
proliferation or differentiation of the keratinocyte. Alternatively, it 
is possible that the epidermal stem cells are refractory to gene 
transfer or become committed to differentiation upon transfection. 
Furthermore, it could be argued that the differentiation under in 
vitro conditions would induce loss of stem-cell function, and thus 
the probability of retaining competent transfected stem cells in the 
graft. However, because we are able to regenerate a well differen-
tiated culture from the basal layer after several rounds of stripping 
off suprabasal cells in calcium free medium [19], we conclude that 
the short period in culture should not severely reduce the fraction of 
stem cells before grafting. 
Despite the problems of not achieving long-term secretion into 
the blood stream we still find the epidermal tissue a promising 
system. However, we need to improve the system. 
1) Steps have been takeh towards prospective identification and 
separation of epidermal stem cells, e.g., based upon high expression 
of integrins [20] . Targeted transfection of such epidermal stem cells 
might make it possible to achieve a prolonged expression of the 
transfected genes in the basal cell layer. 
2) Selection of the transfected primary keratinocytes during cul-
ture would ensure increased numbers of transfected basal cells. Be-
cause neomycin selection has been unsuccessful [5] , attempts have 
been made in this direction by the use of the gene encoding L-histi-
dinol dehydrogenase that renders dog keratinocytes resistant to L-
histidinol [21] . So far we have not been able to adapt this method to 
human primary keratinocytes successfully. 
3) A more stable expression of the introduced genes in the basal 
cell layer might be achieved by the use of an endogenous promoter 
(e.g., the keratin 14 promoter), which is exclusively active in the 
basal cells. 
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4) If inefficient secretion from the cel ls through the basement 
membrane turns out to be the problem, chimeric proteins may be 
constructed to improve this transport. Properties of the Apo E pro-
tein might be of interest in this context because this molecule has 
clearly been shown to be efficiently transported fro m the epidermis 
to the circulation [4) . 
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